Search

everythinglearnresearchcommunity

for

Search:↓

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

High-frequency ultrasonography can be a useful tool for diagnosing different stages of alopecia areata, a type of hair loss.

A patient regrew hair after a lung transplant using standard post-transplant medication.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

Women and people with skin of color are more likely to be misdiagnosed with alopecia areata.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

Apremilast did not work for treating severe alopecia areata.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Eosinophils are not a reliable marker for diagnosing alopecia areata.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

Upadacitinib may cause hair loss.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Alopecia areata causes varying hair loss and nail changes, and treatments include topical, systemic, and injectable therapies.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

AB+ blood group is more common in alopecia areata patients.

Patients and doctors often disagree on alopecia areata severity and treatment satisfaction.

Minoxidil was promising for treating male and female pattern baldness in 1994, but more research on genetics and other treatments was needed.

People with alopecia areata are more likely to have other immune-related conditions.

A six-year-old girl unusually had a hair loss condition common in middle-aged women.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

Amla (Indian gooseberry) offers many health benefits and can be used in various products.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Certain genes are linked to the risk of developing Alopecia Areata.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

People with alopecia areata may have a higher risk of thyroid diseases.